NasdaqGM - Nasdaq Real Time Price USD
KalVista Pharmaceuticals, Inc. (KALV)
At close: November 7 at 4:00 PM EST
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Operating Cash Flow
-102,721.00
-89,231.00
-75,261.00
-78,134.00
-30,171.00
Investing Cash Flow
-67,170.00
-84,719.00
41,415.00
57,860.00
-147,654.00
Financing Cash Flow
153,510.00
150,714.00
58,116.00
1,581.00
212,117.00
End Cash Position
33,028.00
31,789.00
56,238.00
30,732.00
50,592.00
Capital Expenditure
-522.00
-443.00
-1,196.00
-931.00
-82.00
Issuance of Capital Stock
--
96,945.00
56,582.00
--
210,582.00
Free Cash Flow
-103,243.00
-89,674.00
-76,457.00
-79,065.00
-30,253.00
4/30/2021 - 4/9/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHVS Pharvaris N.V.
22.32
-10.76%
ASND Ascendis Pharma A/S
126.55
-2.17%
IRON Disc Medicine, Inc.
63.33
-2.27%
MRUS Merus N.V.
54.50
+2.58%
KROS Keros Therapeutics, Inc.
67.17
+1.08%
SNDX Syndax Pharmaceuticals, Inc.
21.52
+0.80%
ANAB AnaptysBio, Inc.
21.49
-3.24%
KURA Kura Oncology, Inc.
17.77
-0.39%
PTGX Protagonist Therapeutics, Inc.
47.61
+0.02%
ATXS Astria Therapeutics, Inc.
11.77
-0.84%